Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Initiating your retirement plan at the right time is crucial for building a secure future. Understand the best timing for your finances.
20,539 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Celsius investors are watching how 2025 earnings unfold as the company scales international growth, expands product l...
March is a pivotal time for industrial stocks as infrastructure and defense themes collide with energy transition dem...
Rising housing costs strain households and the broader economy. Smart tax policy can lower those costs by acceleratin...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
Discover FitLife's 2025 earnings story, from revenue drivers to margins and cash flow. This guide breaks down what th...
A $650,000 portfolio could potentially cover a yearly luxury trip if the income approach is right, balancing high-yie...
In the first half of 2026, SanDisk sprinted to the top of the market, earning the label sandisk stock biggest winner....
Investors eye a single ETF as the simplest path for the rest of 2026 amid AI-driven gains and shifting rate expectati...
Mativ's 2025 earnings cycle reveals a company navigating macro headwinds with disciplined execution. This article bre...
Geopolitical tensions push markets lower as inflation and energy risk linger. This piece analyzes Coca-Cola as a cand...
March 2026 sees a surge in MetaStock alternatives as traders seek real-time data, AI insights, and cloud-based tools....